脑卒中合并稳定性冠心病运动康复专家共识

2018-04-30 上海市康复医学会心脏康复专业委员会 中国康复医学杂志.2018.33(4):379-384..

脑卒中后多数患者存在不同程度的肢体运动功能障碍,61.9%的非致死性卒中后患者冠脉造影有冠脉斑块,卒中后心肌梗死发病率为2.2%,由于偏瘫患者大部分倾向于坐位生活方式,其运动耐量(包括心肺耐力和肌耐力)下降,同时肢体肌力、肌张力、运动模式、运动灵活性、技巧性异常,故其步行活动的能量消耗大于肢体功能正常的人,因此心脏负荷增加,从而可能增加运动相关的心血管事件的发生。运动康复是心血管康复的核心措施之一

中文标题:

脑卒中合并稳定性冠心病运动康复专家共识

发布日期:

2018-04-30

简要介绍:

脑卒中后多数患者存在不同程度的肢体运动功能障碍,61.9%的非致死性卒中后患者冠脉造影有冠脉斑块,卒中后心肌梗死发病率为2.2%,由于偏瘫患者大部分倾向于坐位生活方式,其运动耐量(包括心肺耐力和肌耐力)下降,同时肢体肌力、肌张力、运动模式、运动灵活性、技巧性异常,故其步行活动的能量消耗大于肢体功能正常的人,因此心脏负荷增加,从而可能增加运动相关的心血管事件的发生。运动康复是心血管康复的核心措施之一,是指在综合评定的基础上,通过运动处方和运动指导的方式,采用适当的机体运动来帮助患者恢复生活能力,促进心身健康的一种康复手段。脑卒中合并冠心病患者运动康复应控制脑卒中与冠心病共同的危险因素(高血压病、血脂异常、高血糖、超重和肥胖),降低卒中和冠心病事件的发生风险,提高患者的运动耐量和功能性活动能力。 

拓展指南:脑卒中相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=脑卒中合并稳定性冠心病运动康复专家共识)] GetToolGuiderByIdResponse(projectId=1, id=965761c0015925ab, title=脑卒中合并稳定性冠心病运动康复专家共识, enTitle=, guiderFrom=中国康复医学杂志.2018.33(4):379-384.., authorId=null, author=, summary=脑卒中后多数患者存在不同程度的肢体运动功能障碍,61.9%的非致死性卒中后患者冠脉造影有冠脉斑块,卒中后心肌梗死发病率为2.2%,由于偏瘫患者大部分倾向于坐位生活方式,其运动耐量(包括心肺耐力和肌耐力)下降,同时肢体肌力、肌张力、运动模式、运动灵活性、技巧性异常,故其步行活动的能量消耗大于肢体功能正常的人,因此心脏负荷增加,从而可能增加运动相关的心血管事件的发生。运动康复是心血管康复的核心措施之一, cover=, journalId=null, articlesId=null, associationId=1651, associationName=上海市康复医学会心脏康复专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Mon Apr 30 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>脑卒中后多数患者存在不同程度的肢体运动功能障碍,61.9%的非致死性卒中后患者冠脉造影有冠脉斑块,卒中后心肌梗死发病率为2.2%,由于偏瘫患者大部分倾向于坐位生活方式,其运动耐量(包括心肺耐力和肌耐力)下降,同时肢体肌力、肌张力、运动模式、运动灵活性、技巧性异常,故其步行活动的能量消耗大于肢体功能正常的人,因此心脏负荷增加,从而可能增加运动相关的心血管事件的发生。运动康复是心血管康复的核心措施之一,是指在综合评定的基础上,通过运动处方和运动指导的方式,采用适当的机体运动来帮助患者恢复生活能力,促进心身健康的一种康复手段。脑卒中合并冠心病患者运动康复应控制脑卒中与冠心病共同的危险因素(高血压病、血脂异常、高血糖、超重和肥胖),降低卒中和冠心病事件的发生风险,提高患者的运动耐量和功能性活动能力。 </div> <div><br> </div>拓展指南:<strong>与<font color="red">脑卒中</font>相关指南:</strong><br><ul><li><a title="中国急性脑卒中临床研究规范共识2018" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=576cb1c00159194a">中国急性脑卒中临床研究规范共识2018</a></li> <li><a title="解读美国心脏协会/美国卒中协会无症状性脑血管病患者脑卒中预防的科学声明" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=7d5a71c001582976">解读美国心脏协会/美国卒中协会无症状性脑血管病患者脑卒中预防的科学声明</a></li> <li><a title="中国急性缺血性脑卒中中西医急诊诊治专家共识" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=cd7ce1c0015e2945">中国急性缺血性脑卒中中西医急诊诊治专家共识</a></li> <li><a title="2017 AHA/ASA科学声明:急性缺血性脑卒中静脉阿替普酶溶栓后出血性转化的治疗和结局" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=baaaf1c00151e87e">2017 AHA/ASA科学声明:急性缺血性脑卒中静脉阿替普酶溶栓后出血性转化的治疗和结局</a></li> <li><a title="脑血管健康管理与脑卒中早期预防专家共识" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=780251c00151a615">脑血管健康管理与脑卒中早期预防专家共识</a></li> 更多信息请点击:<a target="_blank" href="http://www.medsci.cn/guideline/list.do?q=%E8%84%91%E5%8D%92%E4%B8%AD">有关脑卒中更多指南</a></ul>, tagList=[TagDto(tagId=64, tagName=脑卒中), TagDto(tagId=2696, tagName=稳定性冠心病), TagDto(tagId=7787, tagName=运动康复)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=95, categoryName=康复医学, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8785, appHits=444, showAppHits=7, pcHits=6398, showPcHits=2741, likes=189, shares=28, comments=7, approvalStatus=1, publishedTime=Thu May 17 23:05:50 CST 2018, publishedTimeString=2018-04-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu May 17 23:05:50 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 16:25:14 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=脑卒中合并稳定性冠心病运动康复专家共识)])
脑卒中合并稳定性冠心病运动康复专家共识
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1057813, encodeId=8ab2105e81360, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:31:58 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013527, encodeId=c8d6101352e35, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeb85145483, createdName=14685ec5m56暂无昵称, createdTime=Wed Sep 01 18:14:18 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007447, encodeId=5806100e44700, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d93a5571920, createdName=ms4000000173143414, createdTime=Thu Aug 12 22:35:49 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346572, encodeId=5bd23465e25a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220813/83cbf514a9a04c03be13b0e451aaac66/e305097eb795493bbb43b8fd752275a2.jpg, createdBy=9deb2449004, createdName=虎狗妈, createdTime=Tue Sep 25 14:40:21 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317220, encodeId=75f131e22064, content=非常好.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/21/3ca7e45a5a3a70cdf0a44fb6301db4ff.jpg, createdBy=aa512256377, createdName=121757d6m64(暂无昵称), createdTime=Mon May 21 11:51:32 CST 2018, time=2018-05-21, status=1, ipAttribution=)]
    2021-10-05 H8888888

    受益匪浅

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1057813, encodeId=8ab2105e81360, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:31:58 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013527, encodeId=c8d6101352e35, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeb85145483, createdName=14685ec5m56暂无昵称, createdTime=Wed Sep 01 18:14:18 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007447, encodeId=5806100e44700, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d93a5571920, createdName=ms4000000173143414, createdTime=Thu Aug 12 22:35:49 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346572, encodeId=5bd23465e25a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220813/83cbf514a9a04c03be13b0e451aaac66/e305097eb795493bbb43b8fd752275a2.jpg, createdBy=9deb2449004, createdName=虎狗妈, createdTime=Tue Sep 25 14:40:21 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317220, encodeId=75f131e22064, content=非常好.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/21/3ca7e45a5a3a70cdf0a44fb6301db4ff.jpg, createdBy=aa512256377, createdName=121757d6m64(暂无昵称), createdTime=Mon May 21 11:51:32 CST 2018, time=2018-05-21, status=1, ipAttribution=)]
    2021-09-01 14685ec5m56暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1057813, encodeId=8ab2105e81360, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:31:58 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013527, encodeId=c8d6101352e35, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeb85145483, createdName=14685ec5m56暂无昵称, createdTime=Wed Sep 01 18:14:18 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007447, encodeId=5806100e44700, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d93a5571920, createdName=ms4000000173143414, createdTime=Thu Aug 12 22:35:49 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346572, encodeId=5bd23465e25a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220813/83cbf514a9a04c03be13b0e451aaac66/e305097eb795493bbb43b8fd752275a2.jpg, createdBy=9deb2449004, createdName=虎狗妈, createdTime=Tue Sep 25 14:40:21 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317220, encodeId=75f131e22064, content=非常好.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/21/3ca7e45a5a3a70cdf0a44fb6301db4ff.jpg, createdBy=aa512256377, createdName=121757d6m64(暂无昵称), createdTime=Mon May 21 11:51:32 CST 2018, time=2018-05-21, status=1, ipAttribution=)]
    2021-08-12 ms4000000173143414

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1057813, encodeId=8ab2105e81360, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:31:58 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013527, encodeId=c8d6101352e35, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeb85145483, createdName=14685ec5m56暂无昵称, createdTime=Wed Sep 01 18:14:18 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007447, encodeId=5806100e44700, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d93a5571920, createdName=ms4000000173143414, createdTime=Thu Aug 12 22:35:49 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346572, encodeId=5bd23465e25a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220813/83cbf514a9a04c03be13b0e451aaac66/e305097eb795493bbb43b8fd752275a2.jpg, createdBy=9deb2449004, createdName=虎狗妈, createdTime=Tue Sep 25 14:40:21 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317220, encodeId=75f131e22064, content=非常好.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/21/3ca7e45a5a3a70cdf0a44fb6301db4ff.jpg, createdBy=aa512256377, createdName=121757d6m64(暂无昵称), createdTime=Mon May 21 11:51:32 CST 2018, time=2018-05-21, status=1, ipAttribution=)]
    2018-09-25 虎狗妈

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1057813, encodeId=8ab2105e81360, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:31:58 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013527, encodeId=c8d6101352e35, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeb85145483, createdName=14685ec5m56暂无昵称, createdTime=Wed Sep 01 18:14:18 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007447, encodeId=5806100e44700, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d93a5571920, createdName=ms4000000173143414, createdTime=Thu Aug 12 22:35:49 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346572, encodeId=5bd23465e25a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220813/83cbf514a9a04c03be13b0e451aaac66/e305097eb795493bbb43b8fd752275a2.jpg, createdBy=9deb2449004, createdName=虎狗妈, createdTime=Tue Sep 25 14:40:21 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317220, encodeId=75f131e22064, content=非常好.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/21/3ca7e45a5a3a70cdf0a44fb6301db4ff.jpg, createdBy=aa512256377, createdName=121757d6m64(暂无昵称), createdTime=Mon May 21 11:51:32 CST 2018, time=2018-05-21, status=1, ipAttribution=)]
    2018-05-21 121757d6m64(暂无昵称)

    非常好.学习了

    0